W. Douglas Cress

8.3k citations
86 papers · 6.8k indexed · 2 hit papers · h-index 38
Topics
Cancer-related Molecular Pathways (39 papers)RNA modifications and cancer (18 papers)Lung Cancer Treatments and Mutations (14 papers)

In The Last Decade

W. Douglas Cress

85 papers receiving 6.8k citations

Hit Papers

Expression of transcription factor E2F1 induces quiescent...199320262004201519932000250500750

Peers

W. Douglas Cress
Comparison fields: 5 of 124
  • Molecular Biology 4.8k
  • Oncology 2.8k
  • Cancer Research 1.2k
  • Immunology 825
  • Genetics 775
Replace Maria Laura Avantaggiati with:
Maria Laura Avantaggiati United States
Gerardo Ferbeyre Canada
Steven B. McMahon United States
Asha S. Multani United States
Jason D. Weber United States
Lisa Wiesmüller Germany
Siavash K. Kurdistani United States
Peter M. Chumakov Russia
Colin Nixon United Kingdom
P A Marks United States
W. Douglas Cress relative to Maria Laura Avantaggiati United States Maria Laura Avantaggiati's profile →
Citations per field
00.5×
Maria Laura Avantaggiati · 1×
Citations per year

Countries citing papers authored by W. Douglas Cress

Since Specialization
Citations

This map shows the geographic impact of W. Douglas Cress's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Douglas Cress with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Douglas Cress more than expected).

Fields of papers citing papers by W. Douglas Cress

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Douglas Cress. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Douglas Cress. The network helps show where W. Douglas Cress may publish in the future.

Co-authorship network of co-authors of W. Douglas Cress

This figure shows the co-authorship network connecting the top 25 collaborators of W. Douglas Cress. A scholar is included among the top collaborators of W. Douglas Cress based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Douglas Cress. W. Douglas Cress is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 21
4 4
5 17
6 88
7 15
8 80
9 151
10 33
11 67
12 181
13
Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1.
91
14 38
15 21
16 28
17 116
18 58
19 52
20 13

About W. Douglas Cress

W. Douglas Cress is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 86 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (39 papers), RNA modifications and cancer (18 papers) and Lung Cancer Treatments and Mutations (14 papers). The work is most often cited by research in Oncology (2.8k citations), Cancer Research (1.2k citations) and Geriatrics and Gerontology (288 citations). W. Douglas Cress has collaborated with scholars based in United States, Puerto Rico and Spain. Frequent co-authors include Joseph R. Nevins, Steven J. Triezenberg, D. Gale Johnson, Edward Seto, Yihong Ma, James K. Schwarz, Eric B. Haura, Matthew B. Schabath, Domenico Coppola and Jiandong Chen. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026